ArticleJournal of animal science and biotechnology2025
Dietary supplementation with sodium isobutyrate enhances growth performance and colonic barrier function in weaned piglets via microbiota-metabolite-host interactions.
Article in Journal of animal science and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Mechanically activated zinc oxide enhances growth performance and protects against diarrhea with potentially regulating gut microbiota in weaned piglets.Animal nutrition (Zhongguo xu mu shou yi xue hui) · 2026Article
- Saffron Alters Microbial Amino Acid Metabolism and Neurotransmitter Production in a Defined Gut Consortium.Food science & nutrition · 2026Article
- Effects of feeding pelleted complete diets containing palm fronds on growth performance, nutrient digestibility, intraruminal fermentation, rumen histomorphology, carcass traits, and economic profitability in Awassi lambs.Frontiers in veterinary science · 2026Article
- Polyamines as a Universal Language of Host-Microbiota Symbiosis.Research (Washington, D.C.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundWeaning-induced diarrhoea and growth retardation in piglets are associated with impaired intestinal barrier function and decreased levels of colonic short-chain fatty acids (SCFAs). Although SCFA supplementation has been proposed to mitigate these issues, the efficacy and optimal dosage of sodium isobutyrate remain unclear.
resultsWe investigated the effects of sodium isobutyrate supplementation (500, 1,000, 2,000, and 4,000 mg/kg diet) on weaned piglets (Duroc × Landrace × Yorkshire, 28 d of age; n = 8). After a 28-d feeding trial, supplementation at 500-2,000 mg/kg significantly improved average daily gain and feed efficiency and reduced diarrhoea frequency, with maximal benefits observed at 1,000 mg/kg (P < 0.0001). Additionally, 500-1,000 mg/kg sodium isobutyrate supplementation increased the apparent digestibility of crude protein, organic matter, and crude fibre (P < 0.05). Serum biochemical parameters were unaffected, although secretory immunoglobulin A (SIgA) levels significantly increased upon supplementation with 500-1,000 mg/kg (P < 0.05). 16S rRNA gene sequencing indicated that sodium isobutyrate increased the abundance of beneficial colonic microbiota. The 1,000 mg/kg group presented the most pronounced effect, with a significant increase of the relative abundance of Prevotella and the greatest improvement in SCFA concentrations (P < 0.05). Metabolomics revealed elevated levels of colonic indole-3-lactic acid and 3-hydroxybutyrate upon supplementation with 1,000 mg/kg (P < 0.05). Transcriptomic analyses indicated activation of protein digestion and absorption pathways, and PI3K-Akt signalling, marked by TSG-6 upregulation and the suppression of ISG15 and DDIT4 expression (P < 0.05). Supplementation with 1,000 mg/kg was associated with improved intestinal barrier-related markers, including reduced serum D-lactate, diamine oxidase, and lipopolysaccharide levels, increased tight junction protein expression; activation of G protein-coupled receptors; and inhibition of TLR4/MyD88/NF-κB signalling (P < 0.05), suggesting enhanced barrier function.
conclusionsIn conclusion, dietary supplementation with 1,000 mg/kg sodium isobutyrate was associated with improved intestinal morphology, reduced serum permeability, increased expression of tight junction proteins, and enhanced immune function in weaned piglets, suggesting enhanced colonic barrier function and providing dosage guidance and mechanistic insights for future applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.